Search

Genetics and the newborn hearing screen: the future is now

Eliot Shearer shares the progress being made with newborn hearing screening 60 years on from where it started, and future directions for identifying hearing loss using physiologic, genetic and cCMV screening. Newborn screening had its birth in the early 1960s,...

Audiological management of autistic children

Philippa James and Lucy Shiels explain the development of the ‘Autism Listening Clinics’, highlighting a recommended clinical approach for audiologists, the importance of remote microphone technology and sharing some wonderful caregiver experiences. Auditory challenges in autistic children Autism spectrum disorder...

Cochlear implantation in children with single-sided deafness: rationale and early findings

Cochlear Implantation (CI) in children with single-sided deafness (SSD) is a controversial treatment option. Profs Karen Gordon, Papsin and Cushing discuss the rationale and early findings on the relative success of achieving binaural hearing for SSD with CI. If you’d...

What you need to know about recent advances in genetics of hearing loss in the newborn

Identifying the underlying genetic cause of hearing loss in newborns can improve dramatically the early diagnosis and appropriate intervention. Hearing loss is the most common sensory disorder at birth, affecting approximately two out of 1000 newborns [1]. Congenital impaired hearing...

Early detection pathways for congenital cytomegalovirus for infants referred from the newborn hearing screen

This article discusses requirements for an early congenital cytomegalovirus (cCMV) detection pathway to ensure children do not miss out on the opportunity for timely diagnosis and treatment. The pathways described are currently in use in England and apply to well...

Hidden genetic disorders in children that may present to the otolaryngologist

Background Among the many hundreds of children presenting to the otolaryngology clinic are a few whose symptoms are due to an underlying genetic condition. In most cases the underlying syndrome is obvious and has already been diagnosed, such as the...

Intratympanic steroids in Ménière's disease: what’s the evidence?

The days of drastic surgery for Ménière's disease are long gone. We know that intratympanic injections can deliver high doses of medication to the inner ear with minimal discomfort and minimal risk. But how do we choose from the myriad...

Genomic testing for deafness and its implications

Gene therapies for hearing loss are rapidly advancing and will be transitioning to clinical practice. Here, the authors explain why clinicians involved in managing these disorders need to be aware of these advances. Genomic testing in England was significantly reconfigured...

Mobile technologies to support global ear and hearing care

By combining mobile technology with artificial intelligence, more people can access ear and hearing care. The World Health Organization (WHO) estimates that worldwide, nearly half a billion people have moderate or worse hearing loss [1]. The vast majority of people...

Multi-channel cochlear implants: past, present and future

Forty years since the first multi-channel devices were implanted, who better than Ingeborg Hochmair, who has been a key figure throughout their evolution, to offer her thoughts on the past, present and future of multi-channel cochlear implants? Read on for...

In conversation with Prof Helge Rask-Andersen: on cell regeneration and treatment of human deafness

Helge Rask-Andersen, head of the inner ear research laboratory at the University of Uppsala in Sweden, has many achievements to his name. He was made an Honorary Member of ENT UK earlier this year. Gerry O’Donoghue caught up with him...